(Q42519924)

1 November 2017

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients (English)

1 reference

1 November 2017

1 reference

7

Jorge S Reis-Filho

1 reference

1 November 2017

6

Mitch Dowsett

1 reference

1 November 2017

David S P Tan

1

1 reference

1 November 2017

Caterina Marchió

2

1 reference

1 November 2017

Robin L Jones

3

1 reference

1 November 2017

Kay Savage

4

1 reference

1 November 2017

Ian E Smith

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

6 October 2007

1 reference

Breast Cancer Research and Treatment

1 November 2017

1 reference

1 November 2017

111

1 reference

1 November 2017

27-44

1 reference

1 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-007-9756-8

1 November 2017

0 references

cites work

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10549-007-9756-8

Crossref

reference URL

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-007-9756-8

Crossref

reference URL

10.1007/S10549-007-9756-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference